Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease.

Alzheimers Dement · 2025 · PMC12514939 · PMID 41074913

Europe PMC DOI

hedged sentences

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

marginal significancep = 0.069so close (0.05 < p ≤ 0.1)

p‐Tau 217 levels measured by the remaining assay platforms showed similar trends across BMI groups, but reached only marginal significance: Fujirebio (0.20 [SD = 0.26], 0.17 [SD = 0.27], 0.10 [SD = 0.08]; p = 0.069), Alzpath (0.40 [SD = 0.27], 0.38 [SD = 0.29], 0.30 [SD = 0.17]; p = 0.103), and Janssen (0.06 [SD = 0.04], 0.05 [SD = 0.04], 0.04 [SD = 0.03]; p = 0.083).

also in 3,507 other papers

marginally significantno p-value reported

In this study, p values ≤ 0.05 were considered significant, while p values ≤ 0.10 were considered marginally significant. 2.6.1.

also in 17,465 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.